NYMC Faculty Publications
In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
Author Type(s)
Faculty
DOI
10.1016/j.jtct.2024.07.011
Journal Title
Transplantation and Cellular Therapy
First Page
942
Last Page
954
Document Type
Editorial
Publication Date
10-1-2024
Department
Medicine
Keywords
Immune effector cell therapy, Patient safety, quality of care, Quality improvement, Transplant and cellular therapy
Disciplines
Medicine and Health Sciences
Abstract
Immune effector cell (IEC) therapy represents a transformative advancement in oncology, leveraging the immune system to combat various malignancies. This article outlines a comprehensive framework for establishing and maintaining quality standards in IEC therapy amidst rapid scientific and clinical advancements. We emphasize the integration of structured process measures, robust quality assurance, and meticulous outcome evaluation to ensure treatment efficacy and safety. Key components include multidisciplinary expertise, stringent accreditation protocols, and advanced data management systems, which facilitate standardized reporting and continual innovation. The collaborative effort among stakeholders—ranging from patients and healthcare providers to regulatory bodies—is crucial in delivering high-quality IEC therapies. This framework aims to enhance patient outcomes and cement the role of IEC therapy as a cornerstone of modern oncology, promoting continuous improvement and adherence to high standards across the therapeutic spectrum.
Recommended Citation
Dandoy, C., Adams, J., Artz, A., Bredeson, C., Dahi, P., Dodd, T., Jaglowski, S., Lehmann, L., LeMaistre, C., Mian, A., Neal, A., Page, K., Rizzo, J., Rotz, S., Sorror, M., Steinberg, A., Viswabandya, A., & Howard, D. (2024). In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy. Transplantation and Cellular Therapy, 30 (10), 942-954. https://doi.org/10.1016/j.jtct.2024.07.011
